Affinity BioCeuticals

Affinity BioCeuticals is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, recognized as the state's first cannabis-focused biotech firm. Founded by Christina DiArcangelo, the company specializes in the development and clinical validation of cannabinoid-based therapeutics targeting oncology, inflammatory diseases, and rare conditions. It operates in close coordination with its sister organization, Affinity Bio Partners, a clinical research organization, to ensure its products meet rigorous pharmaceutical and regulatory standards. The company aims to bridge the gap between traditional medicine and medical cannabis through evidence-based research and structured clinical trials. Affinity BioCeuticals is part of a broader ecosystem of patient-centric organizations dedicated to improving access to innovative and safe treatment options.